SK Chemicals announced its executive appointments for 2025 on the 5th.


SK Chemicals appointed Hyunseon Park, head of the Pharma Planning Office, as the head of the Pharma business overseeing the pharmaceutical division. CEO Park, a pharmacy major, has extensive experience in marketing, development, and strategy. She has built deep insight and expertise in the pharmaceutical and bio business while serving as the head of the Pharma Planning Office.


Hyunseon Park, CEO of the perm business. Provided by SK Chemicals

Hyunseon Park, CEO of the perm business. Provided by SK Chemicals

View original image

The company stated, "CEO Park is the right person to lead the Pharma business at a time when it is necessary to advance the existing core business areas while establishing mid- to long-term growth strategies and optimizing the business portfolio."



Additionally, SK Chemicals appointed Wonjae Yoon, head of the Application Development Office, as a new executive.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing